Surgical glues also known as surgical adhesives or sealants are used after a traumatic injury or surgery to fix internal or external tissue together. Surgical glues are excellent materials for wound closure as they use a chemical bond to hold tissue together for healing or to aid as a barrier to stop the flow of bodily fluids. They offer advantages over conventional approaches such as sutures and staples. The five main types of surgical glues are fibrin sealants, cyanoacrylates, glutaraldehyde glues, hydrogels, and collagen based compounds. However, scientists in the U.S. have recently created a highly elastic surgical glue that can quickly seal even the toughest wounds in seconds without stitches or staples. The new glue known as MeTro seals the wound and sets in 60 seconds once treated with UV light. The glue composed from a special material contains a degrading enzyme that can last from hours to months and dissolves once the wound is healed. The new glue is said to be ideal for sealing complex wounds in tissues that would repeatedly expand and relax such as heart, lungs, and arteries.
Rising prevalence of traumatic injuries is expected to accelerate the growth of surgical glues market
The factors that are contributing to the growth of the global surgical glue market are rising number of traumatic injuries. For instance, According to the Centers for Disease Control and Prevention (CDC) in 2014, around 2.5 million people were hospitalized due to injuries. Moreover, replacement of conventional sutures and staples with surgical glues having exceptional characteristics such as increase in bond strength, biocompatibility, versatility, and degradation. Rising prevalence of various disorders such as obesity and cardiovascular diseases and increasing need to manage blood loss in patients are the factors that are contributing to the growth of the surgical glue market. However, environment and safety issues with increased stringent regulations for the production of medical grade products are hindering the growth of surgical glue market
Surgical Glues Market Taxonomy:
The global surgical glues market is segmented into material type, application, end user, and geography
On the basis of product, the global surgical glues market is segmented into:
- Polymeric Hydrogels
- Urethane Based Adhesives
On the basis of application, the global surgical glues market is segmented into:
- Cardiovascular Surgeries
- Orthopedic Surgeries
- Urological Surgeries
- Cosmetic Surgeries
- Pulmonary Surgeries
- Central Nervous System Surgeries
On the basis of end user, the global surgical glues market is segmented into:
- Ambulatory Surgical Centers
- Specialty Clinics
On the basis of regions, the global surgical glues market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold a dominant position in the global surgical glues market, owing to the rising demand of surgical glues essentially tissue friendly glue. For instance, according to the TMC Innovation Institute, in 2017 around 50 million surgeries and around 30 million accidents occur annually in the U.S., which need some form of wound closure. Conventionally, wounds were closed using either suturing, stapling or cauterization. However, critical challenges were associated with it such as post-surgery leakage out of suture and staple lines. Furthermore, Asia Pacific is expected to be the fastest growing region in the global surgical glue market. This is mainly due to growing development of clinical specialty, application specific product formulation, and all-purpose products that provide faster sealing, hemostasis or closure for general wound applications in internal and external use.
Seal V the protein free vascular sealant developed by Sealantis is expected to propel the growth of surgical glues market
The major players involved in the surgical glues market include Advanced Medical Solutions, Adhesys Medical, CryoLife, LifeBond, Covalon Technologies, Ocular Therapeutics, Arch Therapeutics, Sealantis, and Suneris. The key players are focusing on strategic mergers and acquisition and development of innovative products so as to establish a significant position in the global surgical glues market. For instance, Sealantis in 2017 is expected to launch its pipeline product Seal-V which is the fastest, safest and most effective vascular sealant. Seal-V is a protein free strong biocompatible vascular sealant that allows precise control of the curing process for the vascular surgeries.